Effectiveness and tolerability of liraglutide for the management of weight regain following sleeve gastrectomy
Obesity Science & Practice2023Vol. 10(1), pp. e706–e706
Citations Over TimeTop 10% of 2023 papers
Mohammad H. Jamal, Wafa Qasem, Fatima Hamshari, Carol Dsouza, Nagi Alqallaf, Paul Kuodi, Chukwudi A Nnaji
Abstract
The use of liraglutide may be an effective adjunct treatment for weight optimization following SG. Maximizing the tolerable dose may yield greater weight reduction.
Related Papers
- → Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial(2016)310 cited
- → After 10 Years of Clinical Trials with Liraglutide in Diabetes, What do we Know About its Effects on Clinical Cardiovascular Outcomes?(2015)4 cited
- → The effects and side effects of liraglutide as a treatment for obesity(2022)2 cited
- → Adding liraglutide to diet and exercise to maintain weight loss – is it worth it?(2021)1 cited
- → Preoperative Diabetes and Early Postoperative Weight Loss Can Predict 1-year Weight Loss Success after Sleeve Gastrectomy(2018)